Your browser doesn't support javascript.
loading
Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation.
Hubert, Steven; Chadwick, Alan; Wacher, Vince; Coughlin, Olivia; Kokai-Kun, John; Bristol, Andrew.
Afiliación
  • Hubert S; Synthetic Biologics, Inc., 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850. Electronic address: shubert@syntheticbiologics.com.
  • Chadwick A; Aesica Formulation Development, Biocity, Pennyfoot Street, Nottingham NG1 1GF, UK.
  • Wacher V; Synthetic Biologics, Inc., 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850.
  • Coughlin O; Synthetic Biologics, Inc., 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850.
  • Kokai-Kun J; Synthetic Biologics, Inc., 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850.
  • Bristol A; Synthetic Biologics, Inc., 9605 Medical Center Drive, Suite 270, Rockville, Maryland 20850.
J Pharm Sci ; 107(2): 662-671, 2018 02.
Article en En | MEDLINE | ID: mdl-28989013

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lovastatina / Estreñimiento / Methanobrevibacter / Síndrome del Colon Irritable / Intestinos / Metano Límite: Animals Idioma: En Revista: J Pharm Sci Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lovastatina / Estreñimiento / Methanobrevibacter / Síndrome del Colon Irritable / Intestinos / Metano Límite: Animals Idioma: En Revista: J Pharm Sci Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos